October 27, 2025

Get Ready for CPHI: Off-Patent Semaglutide and Sustainability in a Shifting World

It’s showtime in Frankfurt – with around 62,000 attendees expected.

The Medicine Maker

October 27, 2025

How Hormones May Influence Tirzepatide Outcomes

Researchers show how reproductive stage and hormone therapy influence weight-loss outcomes in women treated with tirzepatide.

Conexiant

October 27, 2025

Lower GI mistakes: Postop Crohn's, vaccine gaps, colonoscopy errors

There is no routine colonoscopy. Focus on the basics to reduce the impact of inevitable mistakes, done reliably every time.

Conexiant

October 24, 2025

Adoption is key challenge when introducing new dental technology, experts say

After new dental technology has gone through testing and approvals, developers still face the challenge of getting their product adopted.

ADA News

October 24, 2025

Asthma Exacerbations Equal With Two Biologics

Matched asthma cohorts show identical exacerbation rates with differing safety profiles.

Conexiant

October 23, 2025

Nutritional IBD screening tools ranked

Single-center cohort finds MIRT most sensitive at predicting malnutrition or low Fat-Free Mass Index within six months in patients in remission with IBD; SaskIBD-NR shows the highest accuracy for GLIM-defined malnutrition and for low Fat-Free Mass Index.

Conexiant

October 23, 2025

Is the Estradiol Ring Losing Strength Early?

Patients reported return of vasomotor symptoms before the 3-month mark in real-world use. 

Conexiant

October 19, 2025

ADC Improves Outcomes for Patients with Advanced Triple-Negative Breast Cancer Who are Ineligible for Immune Checkpoint Inhibitors

Patients with an aggressive form of breast cancer who are not candidates for immune checkpoint inhibitor therapy showed significantly improved progression-free survival when treated with the antibody drug conjugate sacituzumab govitecan compared to standard chemotherapy.

Dana-Farber

October 17, 2025

2025 American Academy of Ophthalmology Annual Meeting

Topics cover practice management, interventional glaucoma, amniotic membranes, and more.

Ophthalmology Management